HHealth care Read More Johnson & Johnson MedTech submits Ottava surgical robot to FDAJanuary 8, 2026 Johnson & Johnson MedTech (NYSE: JNJ) + announced today that it submitted its Ottava surgical robotic system to…
HHealth care Read More FDA relaxes oversight of AI-enabled devices and wearablesJanuary 6, 2026 Food and Drug Administration Commissioner Marty Makary.ANDREW CABALLERO-REYNOLDS/AFP via Getty Images Lizzy Lawrence leads STAT’s coverage of the…
MMedication Read More Tylenol, Advil, Purina, Haribo face urgent FDA recallJanuary 5, 2026 While a car recall is one notice I never ignore, I can’t ever remember throwing out a single…
MMedication Read More FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)December 29, 2025 PLYMOUTH MEETING, Pa., Dec. 29, 2025 /PRNewswire/ — INOVIO (NASDAQ: INO), a biotechnology company focused on developing and…
MMedication Read More New Oral Wegovy Pill Approved by FDA as Patients Compare Injectable and Compounded Access PathwaysDecember 27, 2025 Summary: Oral pills add flexibility; insurance coverage still varies widely, and compounded options remain unapproved. What “Best Semaglutide”…
MMedication Read More FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMADecember 24, 2025 Approval of YARTEMLEA was based on results from a single-arm, open-label study in adults with TA-TMA (the TA-TMA…
MMedication Read More Novo Jumps on Wegovy Pill ApprovalDecember 23, 2025 This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) gave investors something to cheer after the FDA approved…
MMedication Read More FDA voucher program has led to political interference in drug reviews, staffers sayDecember 19, 2025 WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly…
HHealth Read More CDC grant goes to Danish researchers with ties to Tracy Beth HøegDecember 19, 2025 WASHINGTON — The Centers for Disease Control and Prevention has awarded a $1.6 million grant to controversial researchers at…
MMedication Read More Will FDA Approval of an In‑House Teriparatide Pen Reshape Amphastar Pharmaceuticals’ (AMPH) Narrative?December 18, 2025 In December 2025, Amphastar Pharmaceuticals announced that the FDA approved its abbreviated new drug application for a teriparatide…